胰腺囊性病变的分子病理学,重点是恶性进展
Yan Hu1, Dan Jones1, Ashwini K Esnakula2
1James Molecular Laboratory, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.
Cancers
|March 28, 2024
概括
了解胰腺囊性病变 (PCLs) 的分子变化,特别是导管内皮质粘膜瘤 (IPMNs),是检测早期胰腺癌的关键. 新的遗传发现有助于风险分层和个性化监测策略.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 分子病理学分子病理学
背景情况:
- 胰腺囊性病变 (PCL) 的恶性进展尚未得到充分研究,导致患者风险分层和早期癌症检测方面的知识差距.
- 导管内皮质粘膜瘤 (IPMN) 是一种PCL,可以从低度病变发展为高度病变或侵袭性癌瘤,需要长期监测.
- 炎症在IPMNs的发病和恶性进展中发挥着作用.
研究的目的:
- 审查IPMNs的最新分子发现,包括修订的进展模型和相关的组织学亚型.
- 突出炎症在IPMN病原和恶性进展中的作用.
- 总结PCL分子风险分层的新兴策略,以改善早期胰腺癌检测和个性化管理.
主要方法:
- 对PCL分子病理学现有文献的综述,重点关注恶性进展.
- 对最近的全外因子测序数据的分析,确定IPMN中的新型瘤基因.
- 讨论比较分子分析,证明IPMN的多焦点和多克隆性质.
主要成果:
- KRAS和GNAS是IPMN中主要的致癌驱动因素,通过整个外体序列测序确定了额外的基因.
- IPMNs表现出多焦点和多克隆特征,使分子分析复杂化.
- 新兴的囊采样算法和放射学技术旨在更好地模拟遗传异质性.
结论:
- 对IPMN分子进展的全面理解对于有效监测和最大限度地降低恶性转变风险至关重要.
- 分子风险分层模型,结合放射学和临床特征,可以提高早期胰腺癌检测.
- 基于分子洞察力,正在开发针对PCL的个性化监测和管理策略.
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cystic Fibrosis: Pathogenesis
229
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
229
Chronic Pancreatitis I: Introduction
87
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
87
Chronic Pancreatitis II: Collaborative Care
86
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
86


